It’s only been a few years since all eyes were on the Biotechnology & Healthcare sector during the Covid-19 pandemic. Since then, however, performance has been mixed, According to the AIC, the average discount of investment trusts in the sector sits at 15% and its...
Latest Featured articles
WisdomTree’s Pierre Debru: Signs are pointing higher for bitcoin and cryptocurrencies
After a strong performance in 2023, bitcoin rose 157% over the year, and an eventful January 2024 with the launch of 11 spot bitcoin Exchange-Traded Funds (ETFs) in the US, the signs are looking positive for cryptocurrencies. Looking toward the remainder of the year...
Fundscape publishes the Essential Guide to UK fund Distribution 2024
The UK asset management industry is facing unprecedented challenges: the rise of index solutions and commoditised investments, institutional-type pricing, competition form cash and annuities, not forgetting, of course, the impact of the cost-of-living crisis on...
Robeco’s latest SI dilemma analyses why engagement remains vital to stay on course on climate
Releasing their latest SI Dilemma deep dive this morning, Robeco have reminded us that some large investors recently left the Climate Action 100+ (CA100+) initiative. Their reasons for leaving include concerns over requirements that the new phase of the initiative has...
More Featured stories
BOJ to change interest rate policy? The Week Ahead from Thomas Watts, abrdn
In what's set up to be another week of important economic data, Thomas Watts, Investment Analyst, abrdn Portfolio Solutions, shares his...
Quick Takes on Capital Markets: Short-term bonds: A compelling option in the face of Fed cuts
In the face of impending Federal Reserve rate cuts, investors may want to consider extending duration from Treasury bills to short-term...
China: abrdn’s takeaways from the annual legislative meeting, the National People’s Congress (NPC)
This week, China held its annual legislative meeting, the National People’s Congress (NPC), which saw close to 3,000 delegates from the...
Federated Hermes Weekly Markets Wrap Up: 14 March 2024
Jason DeViito, Lead Portfolio Manager for Emerging Markets Debt at Federated Hermes This week we saw some exciting developments in...
Stick or twist? Will the Fed and BoE make interest rate changes in next week’s meetings? abrdn economists share their thinking
With next week's milestone meetings of both the US Fed and UK's Bank of England - plus UK inflation data due out on Wednesday - it'll be a...
Fed should focus on deflation concerns – key to growth lies in innovation in AI: ARK’s Cathie Wood:
ARK Invest’s CEO, Cathie Wood, believes that the Fed’s fears about inflation are misplaced and deflation should be the main concern. With...
AI – healthcare needs you! Latest investment note from 7IM
David Freitas, Investment Writer, 7IM, is reflecting on last week's Budget speech and the announcement of a big chunk of funds being...
“Impressive” latest investment company ‘dividend heroes’ list revealed by the AIC
The Association of Investment Companies (AIC) has published its latest list of 20 dividend heroes, investment trusts which have...
Podcast #76: SDR labels – The future of the UK sustainability-labelled funds landscape. With Morningstar’s Hortense BioyÂ
Sustainability is back under the microscope after the FCA recently unveiled its Sustainability Disclosure Requirements (SDR) and...
Latest UK GDP stats show growth uptick in January – does that mean the technical recession is over? Investment experts react.
There's been plenty of reaction to the news this morning from the ONS of the latest UK GDP statistics, which show that that UK has grown...
Join our mailing list
Subscribe to our mailing list to receive regular updates!